Douglas S. Tyler
- Oncology top 0.2%
- Cutaneous Melanoma Detection and Management 85
- Pancreatic and Hepatic Oncology Research 55
- CAR-T cell therapy research 35
- Surgery top 0.5%
- Bladder and Urothelial Cancer Treatments 19
- Immunology top 2%
- Immunotherapy and Immune Responses 40
- Cancer Research top 2%
-
- Melanoma and MAPK Pathways 27
-
- Neuroendocrine Tumor Research Advances 21
- Nonmelanoma Skin Cancer Studies 19
- Co-authors
- Theodore N. PappasBryan M. ClaryRebekah R. WhiteHilliard F. SeiglerHerbert I. HurwitzMichael A. MorseScott K. PruittBrian G. Czito
- Journals
- Journal of Biological Chemistry (1 paper)Journal of Clinical Investigation (2 papers)Journal of Clinical Oncology (13 papers)
- Partner nations
- United StatesJapanCanada
In The Last Decade
Douglas S. Tyler
286 papers receiving 9.3k citations
Hit Papers
Peers
Comparison fields: 5 of 142
- Oncology 6.1k
- Surgery 3.4k
- Pulmonary and Respiratory Medicine 2.3k
- Immunology 1.4k
- Cancer Research 896
Countries citing papers authored by Douglas S. Tyler
This map shows the geographic impact of Douglas S. Tyler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas S. Tyler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas S. Tyler more than expected).
Fields of papers citing papers by Douglas S. Tyler
This network shows the impact of papers produced by Douglas S. Tyler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas S. Tyler. The network helps show where Douglas S. Tyler may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Douglas S. Tyler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 3 | |
| 2 | 2021 | 2 | |
| 3 | 2020 | 4 | |
| 4 | 2020 | 4 | |
| 5 | 2020 | 7 | |
| 6 | 2016 | 18 | |
| 7 | 2015 | 144 | |
| 8 | 2014 | 36 | |
| 9 | 2014 | 12 | |
| 10 | 2014 | 8 | |
| 11 | 2012 | 48 | |
| 12 | 2010 | 35 | |
| 13 | 2010 | 19 | |
| 14 | 2009 | 74 | |
| 15 | 2008 | 85 | |
| 16 | 2008 | 4 | |
| 17 | 2008 | 114 | |
| 18 | 2004 | 52 | |
| 19 | 1998 | 54 | |
| 20 | 1995 | 16 |
About Douglas S. Tyler
Douglas S. Tyler is a scholar working on Oncology, Immunology and Surgery, having authored 293 papers that have together received 9.5k indexed citations. Recurring topics across this work include Cutaneous Melanoma Detection and Management (85 papers), Pancreatic and Hepatic Oncology Research (55 papers), Immunotherapy and Immune Responses (40 papers), CAR-T cell therapy research (35 papers), Melanoma and MAPK Pathways (27 papers), Neuroendocrine Tumor Research Advances (21 papers), Bladder and Urothelial Cancer Treatments (19 papers) and Nonmelanoma Skin Cancer Studies (19 papers). The work is most often cited by research in Oncology (6.1k citations), Surgery (3.4k citations) and Pulmonary and Respiratory Medicine (2.3k citations). Douglas S. Tyler has collaborated with scholars based in United States, Japan and Canada. Frequent co-authors include Theodore N. Pappas, Bryan M. Clary, Rebekah R. White, Hilliard F. Seigler, Herbert I. Hurwitz, Michael A. Morse, Scott K. Pruitt, Brian G. Czito, Christopher G. Willett and Georgia M. Beasley. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.